Clinical Trials Browser

Phase 2 × Interventional × iratumumab × Clear all

Hodgkin Disease, Recurrence

NCT00298467 2010-04-26

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Primary Cutaneous Anaplastic Large Cell, Dendritic Cell Sarcoma, Interdigitating

Clinical Trials

A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease

MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma